Related Experiment Video
Updated: Jul 5, 2025

In vitro Investigation of the MexAB Efflux Pump From Pseudomonas aeruginosa
Published on: February 17, 2014
Tracing the substrate translocation mechanism in P-glycoprotein.
Theresa Gewering1,2, Deepali Waghray3, Kristian Parey1,2,4
1Osnabrück University, Department of Biology/Chemistry, Structural Biology Section, Osnabrück, Germany.
P-glycoprotein (Pgp) drug transport was visualized using cryoEM, revealing a novel mechanism where transmembrane helix 1 regulates substrate passage. This finding challenges existing efflux models and identifies new drug targets.
Area of Science:
- Biochemistry
- Structural Biology
- Molecular Biology
Background:
- P-glycoprotein (Pgp) is an ATP-binding cassette (ABC) transporter crucial for drug pharmacokinetics and cancer multidrug resistance.
- Previous studies elucidated Pgp's substrate binding but not the translocation mechanism across membranes.
Purpose of the Study:
- To elucidate the mechanism of substrate translocation through P-glycoprotein.
- To identify key structural elements and conformational changes involved in Pgp-mediated transport.
Main Methods:
- Cryo-electron microscopy (cryoEM) was used to determine structures of Pgp with a covalently attached cyclic substrate in different states.
- Molecular dynamics simulations were employed to trace substrate passage and analyze conformational changes.
- Site-directed mutagenesis of key residues was performed to assess functional impact.
Main Results:
- Multiple cryoEM structures captured Pgp in inward- and outward-facing states during substrate translocation.
- Conformational changes in transmembrane helix 1 (TM1), including a glycine 72 break, were identified as critical regulators of transport.
- A glycine 72 mutation significantly impaired Pgp's in vivo drug transport function.
- Substrate exit was observed without a fully open outward-facing conformation, suggesting a non-canonical efflux model.
Conclusions:
- The study reveals a novel mechanism for P-glycoprotein substrate transport, highlighting the regulatory role of TM1 conformational dynamics.
- The findings challenge the traditional model of ABC transporter efflux and provide critical insights into Pgp function.
- This work identifies potential targets for developing new strategies to overcome Pgp-mediated drug resistance.
More Related Videos
05:28Demonstration of Heterologous Complexes formed by Golgi-Resident Type III Membrane Proteins using Split Luciferase Complementation Assay
Published on: September 10, 2020
13:16Characterization of Membrane Transporters by Heterologous Expression in E. coli and Production of Membrane Vesicles
Published on: December 31, 2019
Related Concept Videos
Carrier-Mediated Transport
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Secondary Active Transport
Drug Absorption Mechanism: Carrier-Mediated Membrane Transport
Facilitated diffusion is a passive process that utilizes human Solute Carrier (SLC) transporters. These transporters bind to the drug, undergo structural...
Cotranslational Protein Translocation
Sec61 channel partners for cotranslational translocation
During cotranslational translocation, the Sec61 channel partners with the signal recognition particle (SRP), the signal recognition particle receptor (SR), and the ribosomes to transport the nascent polypeptide chain...
Facilitated Diffusion
In this process, substrates such as organic compounds and ions interact with a transporter on one side, triggering conformational changes in proteins that enable...
Drug Absorption Mechanism: Passive Membrane Transport